Recently, Westlake Pharm's AI Drug Discovery Enterprise Institute has been officially recognized by the Economy and Information Technology Department of Zhejiang and approved as a Zhejiang Provincial Enterprise Research Institute. Moving forward, the AI Drug Discovery Enterprise Institute and its supporting entity, Westlake Pharm, will work in synergy to accelerate the development of an intelligent drug R&D ecosystem.

An Enterprise Research Institute is a relatively independent technology innovation hub established within a company. It serves as an integral part of the industrial science and technology innovation system and a key pillar supporting the development of Zhejiang's modern industrial system. Provincial-level Enterprise Research Institutes represent high-level R&D organizations, and the qualification process involves stringent requirements regarding R&D investment, talent pool, independent intellectual property, and R&D infrastructure.

The AI Drug Discovery Enterprise Institute will be established and supported by Westlake Pharm. Its objective is to build an AI-powered platform for innovative drug discovery that creates a closed-loop integration of computation and experimentation and ensures end-to-end connectivity between clinical development and industrial application. The institute aims to facilitate the efficient commercialization of basic research findings and establish a distinctive R&D paradigm for first-in-class therapeutics.

Westlake Pharm has long been dedicated to advancing the deep integration of artificial intelligence and novel drug R&D, and has already achieved significant breakthroughs. Leveraging Westlake Pharm 's core technology platforms, the Institute will conduct R&D to tackle key technological challenges in drug discovery, fully unlocking the potential of AI in critical stages such as target identification, molecule discovery, and molecule optimization. The ultimate goal is to accelerate the development of innovative drugs with high clinical value and global competitiveness.

Establishing Enterprise Research Institutes is a key initiative to build the innovation-driven competitiveness of Zhejiang and advance the growth of new quality productive forces tailored to local conditions. This approval reflects a high level of recognition from the government for Westlake Pharm 's technological strength in the AI-powered pharmaceutical field. This is both an honor and a responsibility. In the process of developing the Enterprise Research Institute, the team will fully leverage the technological advantages to drive synergistic development across the provincial industry chain, creating a high-value industrial ecosystem. The company is committed to providing strong support for Zhejiang's goal of building a premier life and health industry cluster and contributing to the high-quality development of China's biopharmaceutical industry.